Enhancement of migration by protein kinase C alpha and inhibition of proliferation and cell cycle progression by protein kinase C delta in capillary endothelial cells

被引:124
作者
Harrington, EO
Loffler, J
Nelson, PR
Kent, KC
Simons, M
Ware, JA
机构
[1] BETH ISRAEL HOSP,DEPT MED,VASC BIOL UNIT,BOSTON,MA 02215
[2] BETH ISRAEL HOSP,DEPT VASC SURG,VASC BIOL UNIT,BOSTON,MA 02215
[3] HARVARD UNIV,SCH MED,BOSTON,MA 02215
关键词
D O I
10.1074/jbc.272.11.7390
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of protein kinase C (PKC) induces angio-gensis, migration, and proliferation of endothelial cells (EC), but can also prevent growth factor-induced EC proliferation, To determine whether these disparate effects are mediated by substrates of individual PKC isoenzymes, PKC alpha and PKC delta were overexpressed in rat microvascular EC. Basal and stimulated migration were enhanced in PKC alpha EC compared with either PKC delta or control EC, Serum-induced growth of PKC delta EC was decreased, while that of PKC alpha cells was similar to control EC, Phorbol ester markedly inhibited PKC delta EC growth but enhanced growth of PKC alpha and control EC. To determine possible causes for this altered proliferation, the effect of PKC delta on adhesion, mitogen-activated protein kinase activity, and cell cycle progression was measured, Adherence of PKC delta EC to vitronectin was significantly enhanced. Serum-induced extracellular signal-regulated kinase-2 activity was increased equally in both PKC alpha and PKC delta EC above that of control, while extracellular signal-regulated kinase-l activity was similar in all EC, Cell cycle analysis suggested that PKC delta EC entered S phase inappropriately and were delayed in passage through S phase, Thus, PKC alpha may mediate some proangiogenic effects of PKC activation; conversely, PKC delta may direct antiangiogenic aspects of overall PKC activation, including slowing of the cell cycle progression.
引用
收藏
页码:7390 / 7397
页数:8
相关论文
共 56 条
  • [1] BASIC FGF ACTIVATES PHOSPHOLIPASE-D IN ENDOTHELIAL-CELLS IN THE ABSENCE OF INOSITOL-LIPID HYDROLYSIS
    AHMED, A
    PLEVIN, R
    SHOAIBI, MA
    FOUNTAIN, SA
    FERRIANI, RA
    SMITH, SK
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1994, 266 (01): : C206 - C212
  • [2] MIGRATION AND PROLIFERATION OF ENDOTHELIAL CELLS IN PREFORMED AND NEWLY FORMED BLOOD-VESSELS DURING TUMOR ANGIOGENESIS
    AUSPRUNK, DH
    FOLKMAN, J
    [J]. MICROVASCULAR RESEARCH, 1977, 14 (01) : 53 - 65
  • [3] SPATIOTEMPORAL SEGREGATION OF ENDOTHELIAL-CELL INTEGRIN AND NONINTEGRIN EXTRACELLULAR MATRIX-BINDING PROTEINS DURING ADHESION EVENTS
    BASSON, CT
    KNOWLES, WJ
    BELL, L
    ALBELDA, SM
    CASTRONOVO, V
    LIOTTA, LA
    MADRI, JA
    [J]. JOURNAL OF CELL BIOLOGY, 1990, 110 (03) : 789 - 801
  • [4] 2 CLOSELY-RELATED ISOFORMS OF PROTEIN-KINASE-C PRODUCE RECIPROCAL EFFECTS ON THE GROWTH OF RAT FIBROBLASTS - POSSIBLE MOLECULAR MECHANISMS
    BORNER, C
    UEFFING, M
    JAKEN, S
    PARKER, PJ
    WEINSTEIN, IB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (01) : 78 - 86
  • [5] FAILURE OF WILD-TYPE OR A MUTANT FORM OF PROTEIN KINASE-C-ALPHA TO TRANSFORM FIBROBLASTS
    BORNER, C
    FILIPUZZI, I
    WEINSTEIN, IB
    IMBER, R
    [J]. NATURE, 1991, 353 (6339) : 78 - 80
  • [6] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS
    BROOKS, PC
    CLARK, RAF
    CHERESH, DA
    [J]. SCIENCE, 1994, 264 (5158) : 569 - 571
  • [7] INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS
    BROOKS, PC
    MONTGOMERY, AMP
    ROSENFELD, M
    REISFELD, RA
    HU, TH
    KLIER, G
    CHERESH, DA
    [J]. CELL, 1994, 79 (07) : 1157 - 1164
  • [8] BUSSOLINO F, 1994, J BIOL CHEM, V269, P2877
  • [9] HEPATOCYTE GROWTH-FACTOR IS A POTENT ANGIOGENIC FACTOR WHICH STIMULATES ENDOTHELIAL-CELL MOTILITY AND GROWTH
    BUSSOLINO, F
    DIRENZO, MF
    ZICHE, M
    BOCCHIETTO, E
    OLIVERO, M
    NALDINI, L
    GAUDINO, G
    TAMAGNONE, L
    COFFER, A
    COMOGLIO, PM
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 119 (03) : 629 - 641
  • [10] CAMUSSI G, 1995, J IMMUNOL, V154, P6492